Abstract

Background: Phthalates are ubiquitous environmental contaminants and some may adversely affect human health. Butylbenzyl phthalate (BBzP), di-n-butyl phthalate (DnBP), and di(2-ethylhexyl) phthalate (DEHP) are being phased out and replaced by substitutes including di-iso-nonyl phthalate (DiNP), and di-iso-decyl phthalate (DiDP), however little is known about consequent trends in population-level exposures. Aims: To examine temporal trends in urinary concentrations of phthalate metabolites in the US general population, and whether trends vary by age, sex, race/ethnicity, or income. Methods: We combined data on 11 phthalate metabolites for 8626 participants from 2001-2002, 2003-2004, 2005-2006, 2007-2008, and 2009-2010 cycles of the National Health and Nutrition Examination Survey. We compared least square geometric mean (LSGM) concentrations of phthalate metabolites by cycle after creatinine adjustment. Results: LSGM concentrations of metabolites of diethyl phthalate (DEP), DnBP, BBzP, and DEHP decreased between 2001-2002 and 2009-2010 (Ptrend < 0.05). The percent decrease in LSGM concentrations ranged from 20% for the DnBP metabolite to 50% for the DEP metabolite and the molar sum of DEHP metabolites (?DEHP metabolites). In contrast, LSGM concentrations of metabolites of di-iso-butyl phthalate (DiBP), DiNP, and DiDP increased 220%, 160%, and 20%, respectively, over the study period (Ptrend < 0.05). Trends varied by age, sex, race/ethnicity, and income (Pinteraction < 0.05). For example, DEHP, DiNP, and DiDP metabolites were higher in children than adults but the gap between the groups narrowed over time. Conclusions: US population exposure to phthalates has changed in the last decade. These trends likely reflect shifts in commercial formulations, public awareness, and regulations.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call